The invention encompasses the novel compound of Formula I as well as a
method of treating COX-2 mediated diseases comprising administration to a
patient in need of such treatment of a non-toxic therapeutically effective
amount of a compound of Formula I.
##STR1##
The invention also encompasses certain pharmaceutical compositions for
treatment of COX-2 mediated diseases comprising compounds of Formula I.